Cargando…

Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease

Identifying patients at higher risk for poor outcomes from nonalcoholic fatty liver disease (NAFLD) remains challenging. Metabolomics, the comprehensive measurement of small molecules in biological samples, has the potential to reveal novel noninvasive biomarkers. The aim of this study was to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wegermann, Kara, Howe, Catherine, Henao, Ricardo, Wang, Ying, Guy, Cynthia D., Abdelmalek, Manal F., Diehl, Anna Mae, Moylan, Cynthia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034573/ https://www.ncbi.nlm.nih.gov/pubmed/33860119 http://dx.doi.org/10.1002/hep4.1665

Ejemplares similares

Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023)

Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
por: Wegermann, Kara, et al.
Publicado: (2018)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Fudim, Marat, et al.
Publicado: (2021)

Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)

Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study
por: Glass, Oliver, et al.
Publicado: (2021)

Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Chen, Tianyi, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease: another leap forward
por: Abdelmalek, Manal F.
Publicado: (2021)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
por: Peters, Anthony E., et al.
Publicado: (2021)

Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD
por: Wegermann, Kara, et al.
Publicado: (2021)

Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
por: Du, Kuo, et al.
Publicado: (2019)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLD
por: Kleinstein, Sarah E., et al.
Publicado: (2018)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2021)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
por: Wang, Caihua, et al.
Publicado: (2019)

Association between cytokines and liver histology in children with nonalcoholic fatty liver disease
por: Perito, Emily R., et al.
Publicado: (2017)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
por: Rana, Rajashree, et al.
Publicado: (2019)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
por: Ren, Zi-Lin, et al.
Publicado: (2022)

A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease
por: Schiöth, Helgi B., et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Zhuyu Pill Alleviates Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism through the Gut–Liver Axis
por: Xu, Lu, et al.
Publicado: (2023)

Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised “Two-Hit” Hypothesis
por: Kakiyama, Genta, et al.
Publicado: (2023)

Dysregulated activation of fetal liver programme in acute liver failure
por: Hyun, Jeongeun, et al.
Publicado: (2019)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2016)

Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
por: Hadi, Hamza El, et al.
Publicado: (2018)

Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study
por: Kasai, Yuki, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Nocturnal Hypoxia Activation of the Hedgehog Signaling Pathway Affects Pediatric Nonalcoholic Fatty Liver Disease Severity
por: Sundaram, Shikha S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ib9e0grkcktvtrlok0umi2cvb6